SS-327

N/A

Report date: 2023/07/05 15:38:33

Base Information

Drug NameSS-327
Drug Alias NameGenSciences-327注射用培重组人凝血因子IX-Fc融合蛋白SS327
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFuren Pharmaceutical Group Co LtdZhengzhou Gensciences Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhengzhou Gensciences Biotechnology Co Ltd
Inactive CompaniesFuren Pharmaceutical Group Co Ltd
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A